Elizabeth A Mittendorf Selected Research

Biological Factors

12/2022	Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
7/2020	Comparative Analysis of Proposed Strategies for Incorporating Biologic Factors into Breast Cancer Staging.
2/2020	Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors.
8/2018	Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System: Review of the Supporting Evidence.
5/2018	Incorporating Biology Into Breast Cancer Staging: American Joint Committee on Cancer, Eighth Edition, Revisions and Beyond.
2/2018	Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer.
11/2017	Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.
11/2017	Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.
1/2017	Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
7/2016	The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth A Mittendorf Research Topics

Disease

190	Breast Neoplasms (Breast Cancer) 05/2024 - 03/2006
141	Neoplasms (Cancer) 03/2024 - 07/2005
31	Triple Negative Breast Neoplasms 04/2024 - 10/2011
21	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2010
18	Pathologic Complete Response 01/2023 - 08/2008
10	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2023 - 01/2011
6	Melanoma (Melanoma, Malignant) 01/2022 - 07/2005
6	Leukemia 01/2019 - 05/2012
6	Hypersensitivity (Allergy) 10/2010 - 12/2007
5	Residual Neoplasm 01/2023 - 12/2009
4	Disease Progression 03/2024 - 03/2002
4	Myeloid Leukemia (Leukemia, Myelocytic) 01/2014 - 05/2012
4	Necrosis 12/2013 - 10/2011
3	Inflammatory Breast Neoplasms 01/2024 - 01/2019
3	Neoplasm Micrometastasis 01/2022 - 01/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 01/2013
3	Hematologic Neoplasms (Hematological Malignancy) 10/2016 - 09/2013
3	Primary Hyperparathyroidism 10/2007 - 03/2002
2	Frailty 11/2023 - 10/2023
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 07/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 10/2016
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
2	Carcinoma (Carcinomatosis) 07/2020 - 10/2006
2	Lymphedema (Milroy Disease) 02/2019 - 06/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 01/2014
2	Lobular Carcinoma 01/2014 - 02/2010
2	Lymphatic Metastasis 12/2010 - 06/2010

Drug/Important Bio-Agent (IBA)

46	Hormones (Hormone)IBA 05/2024 - 12/2008
30	VaccinesIBA 01/2021 - 03/2006
28	Estrogen ReceptorsIBA 01/2024 - 08/2008
28	Peptides (Polypeptides)IBA 01/2024 - 03/2006
22	AntigensIBA 01/2024 - 07/2005
20	Trastuzumab (Herceptin)FDA Link 01/2023 - 08/2006
12	Proteins (Proteins, Gene)FDA Link 10/2023 - 03/2005
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
11	Protein Subunit VaccinesIBA 01/2023 - 08/2006
10	ErbB Receptors (EGF Receptor)IBA 10/2023 - 10/2016
10	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 02/2008
10	Biological FactorsIBA 12/2022 - 07/2016
10	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2016
10	Progesterone Receptors (Progesterone Receptor)IBA 10/2020 - 04/2010
9	human ERBB2 proteinIBA 01/2023 - 02/2012
7	RNA (Ribonucleic Acid)IBA 01/2024 - 04/2014
7	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 10/2008
6	pembrolizumabIBA 01/2023 - 01/2020
6	pertuzumabIBA 01/2023 - 12/2018
5	N-acetyltalosaminuronic acid (NAT)IBA 03/2024 - 09/2015
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2022
5	taxaneIBA 10/2022 - 12/2009
5	LigandsIBA 01/2021 - 04/2014
5	CytokinesIBA 01/2021 - 05/2013
5	Estrogens (Estrogen)FDA Link 01/2021 - 01/2012
5	Cancer VaccinesIBA 10/2018 - 06/2011
4	AnthracyclinesIBA 06/2023 - 12/2009
4	atezolizumabIBA 06/2023 - 10/2020
4	HER2 peptide (369-377)IBA 01/2023 - 01/2019
4	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2020 - 06/2006
4	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2017 - 05/2012
4	EpitopesIBA 01/2013 - 03/2006
3	Tamoxifen FDA LinkGeneric 05/2024 - 12/2022
3	130-nm albumin-bound paclitaxelIBA 06/2023 - 10/2020
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 10/2020
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 01/2015
3	Coloring Agents (Dyes)IBA 12/2020 - 10/2010
3	Cathepsin GIBA 01/2017 - 01/2013
3	Monoclonal AntibodiesIBA 12/2014 - 05/2012
2	Phenobarbital (Luminal)FDA Link 03/2024 - 12/2023
2	AntibodiesIBA 01/2024 - 10/2016
2	ParaffinIBA 01/2023 - 03/2012
2	LipidsIBA 12/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 01/2021
2	GlypicansIBA 10/2022 - 07/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2021
2	talazoparibIBA 01/2022 - 10/2020
2	B7-H1 AntigenIBA 01/2022 - 10/2021
2	eribulin FDA Link 01/2021 - 10/2020
2	InterferonsIBA 01/2021 - 01/2019
2	Blocking AntibodiesIBA 01/2021 - 01/2019
2	ferric oxide (iron oxide)IBA 12/2020 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2007
2	Epidermal Growth Factor (EGF)IBA 12/2018 - 01/2017
2	Colloids (Colloid)IBA 12/2012 - 10/2006

Therapy/Procedure

89	Therapeutics 05/2024 - 02/2004
64	Neoadjuvant Therapy 03/2024 - 01/2008
44	Drug Therapy (Chemotherapy) 04/2024 - 06/2010
41	Immunotherapy 03/2024 - 12/2007
16	Lymph Node Excision (Lymph Node Dissection) 08/2022 - 06/2010
13	Mastectomy (Mammectomy) 10/2023 - 11/2010
12	Segmental Mastectomy (Lumpectomy) 01/2023 - 02/2010
9	Radiotherapy 10/2023 - 11/2010
6	Adjuvant Chemotherapy 04/2024 - 10/2013
4	Aftercare (After-Treatment) 05/2024 - 07/2016
4	Surgical Instruments (Clip) 01/2019 - 08/2014
4	Parathyroidectomy 10/2007 - 03/2002
2	Contraindications 01/2023 - 10/2011
2	Operative Surgical Procedures 05/2018 - 10/2016
2	Stem Cell Transplantation 10/2016 - 01/2014
2	Mammaplasty (Breast Reconstruction) 03/2016 - 05/2011
2	Prophylactic Mastectomy 11/2012 - 08/2010